Matthew Greenhawt Selected Research

Peanut Hypersensitivity (Peanut Allergy)

10/2022	The Case for Prompt Salvage Infant Peanut Oral Immunotherapy Following Failed Primary Prevention.
9/2022	Psychometric parameters of food allergy quality of life during an allergen immunotherapy trial.
11/2021	The Revenge of Unintended Consequences of Anaphylaxis-Risk Overdiagnosis: How Far We Have Come and How Far We Have to Go.
1/2021	Improvements in Quality of Life in Children Following Epicutaneous Immunotherapy (EPIT) for Peanut Allergy in the PEPITES and PEOPLE Studies.
12/2020	Peanut allergy diagnosis: A 2020 practice parameter update, systematic review, and GRADE analysis.
10/2020	Long-term, open-label extension study of the efficacy and safety of epicutaneous immunotherapy for peanut allergy in children: PEOPLE 3-year results.
1/2020	Development and acceptability of a shared decision-making tool for commercial peanut allergy therapies.
1/2020	Unmet needs of children with peanut allergy: Aligning the risks and the evidence.
12/2019	Effect of Epicutaneous Immunotherapy vs Placebo on Reaction to Peanut Protein Ingestion Among Children With Peanut Allergy: The PEPITES Randomized Clinical Trial.
1/2019	Peanut allergy: Burden of illness.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthew Greenhawt Research Topics

Disease

35	Hypersensitivity (Allergy) 01/2022 - 01/2009
32	Anaphylaxis (Anaphylactic Shock) 01/2022 - 01/2009
31	Food Hypersensitivity (Food Allergy) 01/2022 - 11/2012
14	Peanut Hypersensitivity (Peanut Allergy) 10/2022 - 11/2018
10	Asthma (Bronchial Asthma) 11/2022 - 11/2016
8	COVID-19 10/2021 - 01/2020
6	Eczema 01/2022 - 07/2014
5	Enterocolitis 01/2020 - 04/2016
4	Infections 01/2021 - 09/2010
4	Egg Hypersensitivity (Egg Allergy) 01/2020 - 11/2013
4	Eosinophilia 01/2020 - 07/2013
4	Eosinophilic Esophagitis 11/2019 - 07/2013
3	Atopic Dermatitis (Atopic Eczema) 11/2022 - 01/2019
2	Urticaria (Hives) 01/2020 - 01/2020
1	Allergic Rhinitis 11/2022
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2022
1	Communicable Diseases (Infectious Diseases) 10/2021
1	Rhinitis 10/2021
1	Fatigue 04/2021
1	Inflammation (Inflammations) 01/2021
1	Drug Eruptions (Drug Eruption) 01/2020
1	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2020
1	Chronic Urticaria 01/2020
1	Nut Hypersensitivity (Nut Allergy) 01/2018
1	Colic (Abdominal Cramps) 09/2017
1	Proctocolitis (Hemorrhagic Proctocolitis) 09/2017
1	Shock 04/2017
1	Exercise-Induced Asthma (Asthma, Exercise Induced) 11/2016
1	Esophagitis 07/2013
1	Mastocytosis 10/2007

Drug/Important Bio-Agent (IBA)

20	Epinephrine (Adrenaline)FDA LinkGeneric 01/2021 - 01/2017
17	AllergensIBA 01/2022 - 09/2010
14	Immunoglobulin E (IgE)IBA 01/2022 - 07/2013
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2016
7	COVID-19 VaccinesIBA 01/2022 - 01/2021
7	VaccinesIBA 01/2022 - 11/2013
3	mRNA VaccinesIBA 01/2022 - 01/2021
3	Penicillins (Penicillin)FDA Link 11/2021 - 01/2020
3	GlucocorticoidsIBA 01/2020 - 07/2013
3	Proton Pump InhibitorsIBA 01/2020 - 01/2015
2	Messenger RNA (mRNA)IBA 01/2022 - 01/2022
2	Polysorbates (PSML)FDA Link 10/2021 - 01/2021
2	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 10/2021 - 10/2021
2	Omalizumab (Xolair)FDA Link 01/2021 - 01/2020
2	Histamine Antagonists (Antihistamines)IBA 01/2020 - 01/2020
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 01/2009
2	Biomarkers (Surrogate Marker)IBA 01/2019 - 01/2018
2	Pharmaceutical PreparationsIBA 11/2018 - 11/2016
2	Influenza Vaccines (Influenza Vaccine)FDA Link 12/2015 - 11/2013
2	AcidsIBA 01/2015 - 07/2013
1	PrebioticsIBA 11/2022
1	Vaccine ExcipientsIBA 01/2022
1	pegaspargase (Oncaspar)FDA Link 01/2022
1	Adrenal Cortex Hormones (Corticosteroids)IBA 11/2021
1	Excipients (Suspending Agents)IBA 10/2021
1	2019-nCoV Vaccine mRNA-1273IBA 04/2021
1	BNT162 VaccineIBA 04/2021
1	VitaminsIBA 11/2020
1	Vitamin D FDA LinkGeneric 11/2020
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 11/2020
1	mepolizumabIBA 01/2020
1	Contrast MediaIBA 01/2020
1	beta-LactamsIBA 01/2020
1	SDMIBA 01/2020
1	antineoplaston A10 (A 10)IBA 10/2019
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2019
1	BuffersIBA 11/2018
1	2-(4-toluidino)-6-naphthalenesulfonic acid (TNS)IBA 01/2017
1	Biological ProductsIBA 09/2016
1	SteroidsIBA 01/2015
1	AntigensIBA 07/2013
1	Carmine (Natural Red 4)IBA 01/2009
1	TabletsIBA 01/2009
1	Coloring Agents (Dyes)IBA 01/2009
1	MacrolidesIBA 01/2009
1	Azithromycin (Zithromax)FDA LinkGeneric 01/2009
1	Tryptases (Tryptase)IBA 10/2007

Therapy/Procedure

14	Immunotherapy 10/2022 - 11/2012
11	Therapeutics 01/2022 - 11/2012
4	Injections 10/2021 - 11/2018
2	Aftercare (After-Treatment) 01/2021 - 01/2019
2	Premedication 01/2020 - 01/2020
1	Defibrillators (Defibrillator) 01/2022
1	Baths 01/2022
1	Transjugular Intrahepatic Portasystemic Shunt 04/2021
1	Personal Protective Equipment 01/2021
1	Ambulatory Care (Outpatient Care) 07/2020
1	Drug Therapy (Chemotherapy) 01/2020
1	Immunomodulation 01/2020
1	Biological Therapy 01/2020
1	Self Administration (Administration, Self) 01/2020
1	Eye Protective Devices (Goggles) 11/2019
1	First Aid (Aids, First) 01/2019
1	Contraindications 01/2019
1	Conservative Treatment 11/2018